weak fundament continu broad base organ
sale weak continu margin pressur result
improv sequenti visibl remain low
uncertainti around tariff risk asset sale proce
fundament weak continu lot digest
result net receiv poorli market deterior
fundament headlin estim organ sale declin
exclud discontinu oper drove larg drop stock
baby/writ learn develop organ sale declin
food applianc organ sale outdoor live
hurt late spring along top-line weak
expect linger guid lsd declin margin
outlook wors market expect due greater inflat fx
headwind neg impact tariff quantifi could
headwind base tariff import good china
upsid risk tariff increas appl appl basi
prior guidanc estim impli ebit guidanc includ
discontinu oper ad back cent ep headwind
divestitur fall m-hsd somewhat explain stock price
weak said fundament outlook improv sequenti
organ sale expect turn posit lsd guidanc
margin guidanc exclud discontinu oper impli bp
expans net post signific pullback stock risk/reward
begin look bit compel trade
ebitda pro-forma basi howev visibl remain low particularli around
tariff risk asset sale proce thu remain ew
lower pt/estim ep reduc ep estim
midpoint guidanc furthermor
establish new pro-forma ebitda estim exclud discontinu
oper lower pt
base new ebitda estim
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
number includ discontinu oper adj ep
ahead consensu core sale declin
consensu rang organ sale weak driven larg
new learn develop segment write babi
known headwind liquid toy us signific inventori
destock write offic superstor absenc elmer slime
pipelin fill exclud discontinu oper compar
consensu organ sale declin estim gross margin
declin bp y-o-i cost save off-set input cost inflat
neg mix sg sale rose bp y-o-i led
adjust oper margin bp y-o-i adjust oper profit
declin y-o-i priorit de-lever pay
gross debt plan pay increment end
updat guidanc revis guidanc reflect
divestitur waddington rawl busi held sale net sale
expect compar rang
adjust discontinu oper due fx core sale downsid note
sale expect sequenti improv lsd lsd
call broad-bas price increas expect normal
ep prior impact
divestitur waddington rawl compar ep guidanc
unchang although composit lower qualiti lower share
count vs prior
lower interest expens quantifi lower tax rate favor vs
margin exclud discontinu oper expect
larg step driven cost save price increas
help soften impact higher inflat oner fx neg
impact tariff oper cash flow expect
oper cash flow impact divestitur
waddington rawl base busi downsid off-set higher cash
soften retail landscap remain
challeng inventori de-stock
cost busi appear
valuat warrant given lack
visibl trade low
end peer time pro-forma
ev/ebitda start look bit
attract howev earn visibl
risk achiev price
higher commod cost tariff risk
deriv base case scenario
revenu upsid greater synergi realiz drive multipl expans
market share gain drive top-line upsid realiz net
synergi upsid vs forecast drive multipl expans
modest top-line growth augment synergi deliv organ sale
growth start synergi realiz drive om expans
valuat expand modestli ebitda slightli
secularli challeng name epc/tap
revenu downsid tariff risk weaken categori growth drive top-line
downsid tariff risk lower net synergi realiz drive high teen
ebitda downsid vs base case multipl compress
exhibit bear bull revenu transact synergi valu driver
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
